Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125224) titled 'Changes in Hand Bone Mass and Bone Metabolism in Rheumatoid Arthritis Patients after Treatment with Methotrexate or Iguratimod: A Retrospective Study' on May 22.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Zhejiang Provincial People's Hospital
Condition:
Rheumatoid arthritis
Intervention:
Iguratimod group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-22
Target Sample Size: Iguratimod group:36;methotrexate group:34;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=317358
Published...